PALISADE BIO
Palisade Bio is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. They base these treatments on sound science and therapies with a decades-long history of safe and effective usage. The company's mission is to develop and commercialize novel therapeutics that target diseases resulting from a loss of gastrointestinal barrier integrity. Palisade Bio was founded in 2011 and is headquartered in Carlsbad, CA.
PALISADE BIO
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2011-09-06
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.palisadebio.com
Total Employee:
11+
Status:
Active
Contact:
301-366-4960
Email Addresses:
[email protected]
Total Funding:
48.5 M USD
Technology used in webpage:
Google Universal Analytics IPv6 Cloudflare DNS Google Analytics Event Tracking
Similar Organizations
Rheos Medicines
A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.
Rentschler Biopharma SE
Rentschler Biopharma SE is a global full-service contract manufacturer with more than 35 years of experience.
Relypsa
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
RegeneRx
RegeneRx is a biopharmaceutical company that designs, researches, and develops novel peptides targeted at diseases with unmet medical needs.
Nora Therapeutics
Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.
Navidea Biopharmaceuticals
Navidea develops precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
MATINAS BIOPHARMA
A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.
Lumos Pharma
Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Amarillo Biosciences
Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha.
Abalone Bio
Abalone Bio is an early stage biotech start-up that develops antibody drugs for the treatment of diseases.
AVX Pharma
AVX Pharma is a biopharmaceutical company focused on developing novel drugs addressing major ophthalmic unmet medical needs
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Antabio
Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.
Anavex
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Epizyme
Epizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
ENTEROME
Enterome is a clinical-stage company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.
BioMarin Pharmaceutical
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Biowater Technology
Biowater Technology develops biological wastewater treatment processes and equipment for municipal and industrial facilities.
Biologics
Biologics provides a patient-focused platform for managing the financial, emotional, and physical burdens of cancer treatment.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
BAROnova
BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
BioRay Pharmaceutical
BioRay is a commercial-stage biopharmaceutical company in China focusing on immune-mediated diseases and cancer.
Trellis Bioscience
Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.
Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.
Trevena
Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Jennerex Biotherapeutics
Jennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer.
Kures
Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.
Kiadis Pharma
Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.
Krystal Biotech
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Kind Pharmaceutical
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
Worg Pharmaceuticals
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergy and other diseases.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Synaptogenix
Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Dynavax Technologies
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
DiaMedica
DiaMedica is a biopharmaceutical company focused on developing innovative treatments for stroke.
Deciduous Therapeutics
Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
TrainPain
TrainPain is an early stage digital therapeutics company developing an innovative digital treatment for chronic neuropathic pain.
GeNeuro
GeNeuro is a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases.
Gem Pharmaceuticals
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.
Omeros
Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Cytocom
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Cleveland BioLabs
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.
Cardiome Pharma
Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization.
Crestone
Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
9 Meters Biopharma
9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-12-17 | Leading BioSciences, Inc. | Leading BioSciences, Inc. acquired by Palisade Bio | N/A |
Investors List
Yuma Regional Medical Center
Yuma Regional Medical Center investment in Post-IPO Equity - Palisade Bio
Altium Capital
Altium Capital investment in Post-IPO Equity - Palisade Bio
Official Site Inspections
http://www.palisadebio.com Semrush global rank: 1.79 M Semrush visits lastest month: 4.75 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Palisade Bio"
About Us – Overview - Palisade Bio
Our lead program, PALI-2108, is a microbiota-activated PDE4 inhibitor prodrug in development for the treatment of moderate-to-severe ulcerative colitis.See details»
Corporate Governance | Palisade Bio
A leader in several major professional organizations, Dr. Sands has served as the chair of the Clinical Research Alliance of the Crohn’s Foundation of America, Chair of the Immunology, …See details»
Palisade Bio, Inc. - AnnualReports.com
Palisade Bio is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. The Company utilizes over …See details»
Palisade Bio, Inc. (PALI) Company Profile & Facts - Yahoo Finance
See the company profile for Palisade Bio, Inc. (PALI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Palisade Bio - Crunchbase Company Profile & Funding
Palisade Bio is a clinical-stage biopharmaceutical company developing treatments for diseases of unmet medical need. They base these treatments on sound science and therapies with a …See details»
Palisade Bio Launches New Corporate Website and Reiterates …
Aug 1, 2022 New website aligns with company’s mission to become a global leader in addressing diseases linked to intestinal barrier disruption and establishing new standards of …See details»
Palisade Bio - LinkedIn
Palisade Bio (Nasdaq: PALI) is a biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier.See details»
Palisade Bio | Advancing Next-Generation Precision Therapies
Carlsbad, CA, Sept. 16, 2024 — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel …See details»
Palisade Bio, Inc. Company Profile - Dun & Bradstreet
Company Description: Neuralstem is using human neural stem cells to find treatments for central nervous disorders. The company uses a proprietary technology to produce commercial …See details»
Palisade Bio, Inc. (PALI) Company Profile & Overview - Stock Analysis
Ticker Symbol: PALI: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001357459: CUSIP Number: 696389105: ISIN Number: …See details»
Palisade Bio Announces $6 Million Registered Direct Offering and ...
Carlsbad, CA, April 03, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) …See details»
Palisade Bio Enters into Worldwide In-Licensing Agreement
Jul 13, 2021 For more information, please go to www.palisadebio.com. Forward Looking Statements This communication contains “forward-looking” statements, including, without …See details»
Contact - Palisade Bio
Headquarters. 7750 El Camino Real, Suite 2A Carlsbad, CA 92009. Phone: 858.704.4900 Email: [email protected]See details»
Palisade Bio Announces Successful Completion of First GMP …
Jul 11, 2024 The GMP manufacturing was conducted in partnership with Eurofins, a contract development and manufacturing organization. This partnership included process development …See details»
Palisade Bio, Inc. (PALI) Stock Price, Quote & News - Stock Analysis
2 days ago Website https://www.palisadebio.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 2 analysts, the average rating for PALI …See details»
Palisade Bio Launches New Corporate Website and Reiterates …
CARLSBAD, Calif., Aug. 01, 2022 — Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) …See details»
Palisade Bio Announces Closing of $13.8 Million Upsized
Aug 16, 2022 [email protected]. Investor Relations Contact JTC Team, LLC Jenene Thomas 833-475-8247 [email protected] ...See details»
Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 …
Apr 16, 2024 Company continues advancing ongoing development of targeted therapies for ulcerative colitis (UC) Carlsbad, CA, April 16, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. …See details»
Palisade Bio Announces Formation of Clinical Advisory Board with ...
Feb 8, 2024 Palisade Bio is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. The Company believes that by using …See details»